Hymovis™ Versus Placebo in Knee Osteoarthritis

NCT ID: NCT01372475

Last Updated: 2014-04-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

800 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-03-31

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: The purpose of this study is to demonstrate if the intra-articular injection of a new viscoelastic Hydrogel (Hymovis) is superior to Placebo (phosphate buffered saline \[PBS\] in subjects with symptomatic osteoarthritis of the knee.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hymovis Viscoelastic Hydrogel

Intra-articular Injection

Group Type ACTIVE_COMPARATOR

Hymovis Intra-articular Injection

Intervention Type DEVICE

Hymovis Intra-articular injection

Placebo

Phosphate Buffered Saline Intra-articular Injection

Group Type PLACEBO_COMPARATOR

Phosphate Buffered Saline Injection

Intervention Type PROCEDURE

Placebo Intra-articular injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hymovis Intra-articular Injection

Hymovis Intra-articular injection

Intervention Type DEVICE

Phosphate Buffered Saline Injection

Placebo Intra-articular injection

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

HYADD4™ Hyaluronic Acid HA Hyaluronate PBS Saline

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female ambulant outpatients ≥ 40 years of age with an active lifestyle:
2. Has a medical history of OA symptoms confirmed at least 3 months prior to the screening visit with radiographic evidence of OA, Kellgren-Lawrence grade 2-3
3. Discontinuation of any analgesic/NSAID therapy prior to baseline with no intent to resume during study

Exclusion Criteria

1. Clinically significant apparent large effusion of the target knee;
2. Clinically significant valgus/varus deformities, ligamentous laxity or meniscal instability as assessed by the Investigator;
3. Any musculoskeletal condition affecting the target knee that would impair assessment of the effectiveness in the target knee such as Paget's disease
4. Medical history of anaphylactic reactions
5. History of septic arthritis in any joint
6. Females who are pregnant or breast-feeding
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fidia Farmaceutici s.p.a.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cynthia Secchieri, PhD

Role: STUDY_DIRECTOR

Fidia Farmceutici S.p.A.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Achieve Clinical Research, LLC

Birmingham, Alabama, United States

Site Status

Tucson Orthopaedic Institute

Tucson, Arizona, United States

Site Status

Core Orthopaedic

Encinitas, California, United States

Site Status

San Diego Clinical Trials

San Diego, California, United States

Site Status

Norwalk Medical Group

Norwalk, Connecticut, United States

Site Status

Stamford Therapeutics Consortium

Stamford, Connecticut, United States

Site Status

Tampa Bay Medical Research

Clearwater, Florida, United States

Site Status

Homestead Clinical Research

Cutler Bay, Florida, United States

Site Status

SJS Clinical Research

DeFuniak Springs, Florida, United States

Site Status

Avail Clinical Research

DeLand, Florida, United States

Site Status

Riverside Clinical Research

Edgewater, Florida, United States

Site Status

The Andrews Institute

Gulf Breeze, Florida, United States

Site Status

Sun Coast Clinical Research

New Port Richey, Florida, United States

Site Status

Pensacola Research Consultants

Pensacola, Florida, United States

Site Status

Lakeview Medical Research

Summerfield, Florida, United States

Site Status

Drug Studies America

Marietta, Georgia, United States

Site Status

Better Health Clinical Research

Newnan, Georgia, United States

Site Status

Sonora Clinical Research

Boise, Idaho, United States

Site Status

Rush University

Chicago, Illinois, United States

Site Status

Benchmark Research

Metairie, Louisiana, United States

Site Status

UMass Memorial Medical Center

Worcester, Massachusetts, United States

Site Status

Shores Rheumatology

Saint Clair Shores, Michigan, United States

Site Status

Columbus Clinical Research

Columbus, Ohio, United States

Site Status

Radiant Research

Columbus, Ohio, United States

Site Status

Blair Orthopedics Associates & Sports Medicine

Altoona, Pennsylvania, United States

Site Status

Altoona Center for Clinical Research

Duncansville, Pennsylvania, United States

Site Status

University Orthopedic Center

State College, Pennsylvania, United States

Site Status

Radiant Research

Anderson, South Carolina, United States

Site Status

Radiant Research

Greer, South Carolina, United States

Site Status

Tekton Research

Austin, Texas, United States

Site Status

Martin Diagnostic Center

Tomball, Texas, United States

Site Status

Orthopaedic Specialty Clinic

Spokane, Washington, United States

Site Status

Latin Clinical Trial Center

San Juan, , Puerto Rico

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Puerto Rico

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R29-09-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment of Knee Osteoarthritis With PAAG-OA
NCT04045431 ACTIVE_NOT_RECRUITING NA